You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Annexin A1 antibody (ab33061)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab33061? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab33061 has been referenced in 6 publications.

  1. Tsai WH et al. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells. J Cell Physiol : (2012). Flow Cyt. PubMed: 22378018
  2. Tyburczy ME et al. Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic Implications. Am J Pathol 176:1878-90 (2010). IHC-P; Human. PubMed: 20133820
  3. Lilly EA et al. Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety. Mol Oral Microbiol 25:293-304 (2010). ICC; Human. PubMed: 20618702
  4. Wang D et al. Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma. Eur Surg Res 45:151-7 (2010). ICC/IF; Human. PubMed: 20924191
  5. Carmichael ST et al. Genomic profiles of damage and protection in human intracerebral hemorrhage. J Cereb Blood Flow Metab : (2008). PubMed: 18628781
  6. Cao Z et al. Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated, basolaterally targeted exocytic vesicles for proteomics analysis. Mol Cell Proteomics 7:1651-67 (2008). PubMed: 18504258

Publishing research using ab33061? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"